MyAllies NewsBreakingRegulatoryWorldTechnologyBusinessPoliticsEntertainmentHealthSportsTopics
Home › Regulatory

TANDEM DIABETES CARE INC - 8-K Filing

Tandem Diabetes Care receives FDA 510(k) clearance for Tandem Mobi tubeless insulin delivery system (Items: 8.01 Other Events)

2 articles from 2 sources · updated November 13, 2026, 15:01 UTC

Coverage

  • Tandem Diabetes Care Shares Rise 12% Following FDA Clearance of Tubeless Mobi System Seeking Alpha · November 13, 2026, 14:59 UTC
  • TANDEM DIABETES CARE INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:35 UTC